3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
Conditions
Colorectal Neoplasms
62
Carcinoma, Hepatocellular
25
Neoplasm Metastasis
15
Rectal Neoplasms
11
Colonic Neoplasms
10
Gastrointestinal Stromal Tumors
9
Sarcoma
6
Ovarian Neoplasms
5
Osteosarcoma
5
Glioblastoma
5
Cholangiocarcinoma
5
Stomach Neoplasms
4
Melanoma
4
Liver Neoplasms
4
Sarcoma, Ewing
3
Pancreatic Neoplasms
3
Neoplasms
3
Leukemia, Myeloid, Acute
3
Esophageal Neoplasms
3
Colorectal Cancer Metastatic
3
Carcinoma, Non-Small-Cell Lung
3
Thyroid Neoplasms
2
Rhabdomyosarcoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Mesothelioma, Malignant
2
Lymphoma, Non-Hodgkin
2
Hematologic Neoplasms
2
Hemangiosarcoma
2
Gastrointestinal Neoplasms
2
Interventions
Radiotherapy
5
Cisplatin
5
pembrolizumab
4
Cyclophosphamide
4
Thymectomy
3
Sunitinib
3
130-nm albumin-bound paclitaxel
3
selinexor
2
Pemetrexed
2
Methylprednisolone
2
Etoposide
2
Drug Therapy
2
Doxorubicin
2
Chemoradiotherapy
2
Carboplatin
2
zimberelimab
1
vorolanib
1
regorafenib
1
lenvatinib
1
epacadostat
1
envafolimab
1
bosutinib
1
amrubicin
1
Thoracic Surgery, Video-Assisted
1
TP protocol
1
Ramucirumab
1
Radiotherapy, Adjuvant
1
Radiosurgery
1
Radiofrequency Ablation
1
Radiation Dose Hypofractionation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Thymoma
×
regorafenib
×
Clear all
NCT02307500
2022-09-10
RESOUND
Istituto Clinico Humanitas
Phase 2
Completed
82 enrolled